Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) have become a cornerstone treatment for various ophthalmic diseases, particularly wet age-related macular degeneration (AMD). The gene discussed is VEGFA; the disease is age-related macular degeneration.